 Allogeneic marrow transplantation patients positive hepatitis surface antigen patients positive hepatitis surface antigen HBsAg underwent allogeneic marrow transplant malignancy underlying hematologic disease transplant patient serologic evidence hepatitis virus HBV reactivation whereas patients evidence immune response HBV patients serologic follow-up year positive HBsAg HBsAg negative patients clinical evidence venocclusive disease patients acute graft-versus-host disease liver incidence complications similar patients carriers HBsAg patients hepatorenal failure venocclusive disease contribution HBV infection failure unclear Available liver specimens autopsy patients patients HBsAg specimen hepatitis core antigen specimens specimens immunoperoxidase HBV reactivation hepatic failure allogeneic marrow transplant recipients immunocompromised patients increase incidence severe liver disease transplant patients positive HBsAg time transplant positivity HBsAg contraindication marrow transplantation